Post-apoptotic tumors are more palatable to dendritic cells and enhance their antigen cross-presentation activity. (Q39930338)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18848858%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

title

Post-apoptotic tumors are more palatable to dendritic cells and enhance their antigen cross-presentation activity (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18848858%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

0 references

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18848858%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Davide Brusa

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18848858%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Stefano Garetto

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18848858%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Giovanni Camussi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18848858%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

author name string

Maria Scatolini

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18848858%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Elisa Migliore

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18848858%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Lina Matera

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18848858%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

language of work or name

English

0 references

publication date

9 October 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18848858%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

number of pages

11

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18848858%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18848858%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

issue

50

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18848858%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

page(s)

6422-6432

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18848858%20AND%20SRC:MED&resulttype=core&format=json

Dendritic cells and the control of immunity

15 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.063

Dendritic cell immunotherapy: mapping the way.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.063

Natural adjuvants: endogenous activators of dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.063

Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.063

Intracellular and extracellular functions of heat shock proteins: repercussions in cancer therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.063

Heat-shock protein 70 antagonizes apoptosis-inducing factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.063

Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-kappa B pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.063

Interaction of heat shock proteins with peptides and antigen presenting cells: chaperoning of the innate and adaptive immune responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.063

Tumor-derived heat shock protein 70 peptide complexes are cross-presented by human dendritic cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.063

The secretion of HMGB1 is required for the migration of maturing dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.063

High mobility group box-1 protein induces the migration and activation of human dendritic cells and acts as an alarmin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.063

Release of chromatin protein HMGB1 by necrotic cells triggers inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.063

HMGB1 is an endogenous immune adjuvant released by necrotic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.063

High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.063

Release of high mobility group box 1 by dendritic cells controls T cell activation via the receptor for advanced glycation end products

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.063

Immunosuppressive effects of apoptotic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.063

The induction of tolerance by dendritic cells that have captured apoptotic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.063

Immature dendritic cells phagocytose apoptotic cells via alphavbeta5 and CD36, and cross-present antigens to cytotoxic T lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.063

Apoptotic, but not necrotic, tumor cell vaccines induce a potent immune response in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.063

In vitro assessment of dendritic cells pulsed with apoptotic tumor cells as a vaccine for ovarian cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.063

Apoptic renal carcinoma cells are better inducers of cross-presenting activity than their primary necrotic counterpart.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.063

Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.063

Calreticulin exposure dictates the immunogenicity of cancer cell death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.063

Influence of drug-induced apoptotic death on processing and presentation of tumor antigens by dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.063

Drug- and cell-mediated antitumor cytotoxicities modulate cross-presentation of tumor antigens by myeloid dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.063

Amplified RNA synthesized from limited quantities of heterogeneous cDNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.063

Immunologic and clinical responses after vaccinations with peptide-pulsed dendritic cells in metastatic renal cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.063

Antigen-processing machinery breakdown and tumor growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.063

The active translation of MHCII mRNA during dendritic cells maturation supplies new molecules to the cell surface pool

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.063

Immunotherapy and chemotherapy--a practical partnership

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.063

Combined chemoimmunotherapy of solid tumours: improving vaccines?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.063

Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.063

Oncosis is associated with exposure of phosphatidylserine residues on the outside layer of the plasma membrane: a reconsideration of the specificity of the annexin V/propidium iodide assay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.063

Hyperthermia enhances CTL cross-priming

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.063

Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.063

HMGB1 signals through toll-like receptor (TLR) 4 and TLR2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.063

UVC-induced apoptosis in human epithelial tumor A431 cells: sequence of apoptotic changes and involvement of caspase (-8 and -3) cascade

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.063

p53-dependent apoptosis or growth arrest induced by different forms of radiation in U2OS cells: p21WAF1/CIP1 repression in UV induced apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.063

Role for cyclin D1 in UVC-induced and p53-mediated apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.063

Efficient antitumor immunity derived from maturation of dendritic cells that had phagocytosed apoptotic/necrotic tumor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.063

Monocyte-derived dendritic cells loaded with a mixture of apoptotic/necrotic melanoma cells efficiently cross-present gp100 and MART-1 antigens to specific CD8(+) T lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.063

Effective photoimmunotherapy of murine colon carcinoma induced by the combination of photodynamic therapy and dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.063

Cyclophosphamide enhances the antitumor efficacy of adoptively transferred immune cells through the induction of cytokine expression, B-cell and T-cell homeostatic proliferation, and specific tumor infiltration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.063